Terry W Moody Selected Research

PD 134308

7/2015

CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry W Moody Research Topics

Disease

31	Neoplasms (Cancer) 07/2023 - 10/2002
29	Lung Neoplasms (Lung Cancer) 07/2023 - 04/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 04/2002
8	Breast Neoplasms (Breast Cancer) 07/2023 - 10/2002
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 01/2003
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 01/2003
4	Carcinogenesis 03/2009 - 05/2002
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 02/2011
2	Neoplasm Metastasis (Metastasis) 01/2017 - 05/2005
2	Adenocarcinoma 03/2009 - 07/2002
2	Adenoma (Adenomas) 09/2007 - 07/2002
1	Migraine Disorders (Migraine) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Neuroblastoma 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Schizophrenia (Dementia Praecox) 02/2011

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 07/2023 - 09/2006
13	Tyrosine (L-Tyrosine)FDA Link 07/2023 - 05/2002
12	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2002
12	BombesinIBA 01/2021 - 01/2003
10	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 08/2021 - 11/2002
10	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021 - 10/2002
10	Bombesin Receptors (Bombesin Receptor)IBA 01/2021 - 08/2003
9	NeurotensinIBA 07/2023 - 05/2002
8	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2023 - 01/2011
8	ErbB Receptors (EGF Receptor)IBA 07/2023 - 07/2010
6	Tyrosine Kinase InhibitorsIBA 07/2023 - 06/2012
6	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 09/2007 - 10/2002
5	NeuropeptidesIBA 01/2020 - 01/2003
5	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019 - 01/2012
4	Gefitinib (Iressa)FDA Link 07/2023 - 06/2012
4	bombesin receptor subtype 3IBA 01/2018 - 08/2010
4	Cholecystokinin (Pancreozymin)IBA 01/2016 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2002
3	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 12/2019 - 01/2004
3	Cytotoxins (Cytolysins)IBA 01/2018 - 09/2006
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2010
3	Glucose (Dextrose)FDA LinkGeneric 02/2011 - 10/2002
3	CarcinogensIBA 03/2009 - 07/2002
3	Gastrin-Releasing PeptideIBA 02/2008 - 06/2005
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2007 - 05/2004
3	CamptothecinIBA 09/2007 - 05/2004
2	Phosphotransferases (Kinase)IBA 07/2023 - 10/2019
2	SR 48692IBA 07/2023 - 03/2014
2	Amino Acids FDA Link 07/2023 - 12/2019
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2023 - 11/2019
2	Endothelins (Endothelin)IBA 01/2021 - 01/2017
2	Neurotensin Receptors (Neurotensin Receptor)IBA 12/2019 - 05/2002
2	Peptide Receptors (Peptide Receptor)IBA 11/2019 - 09/2016
2	Cell Surface ReceptorsIBA 11/2019 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2018 - 03/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 09/2005
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2016 - 01/2011
2	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2016 - 07/2015
2	GastrinsIBA 01/2016 - 07/2015
2	Metalloproteases (Metalloproteinases)IBA 07/2015 - 08/2011
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2012 - 05/2002
2	neuromedin BIBA 07/2010 - 02/2008
2	S-sulindacIBA 05/2010 - 03/2009
2	2- ((2,6- dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl esterIBA 05/2010 - 03/2009
2	Urethane (Ethyl Carbamate)IBA 09/2007 - 07/2002
2	ThymalfasinIBA 09/2007 - 05/2002
2	AntigensIBA 09/2007 - 01/2004
2	Peptide Hormones (Polypeptide Hormones)IBA 09/2006 - 08/2004
2	BromidesIBA 09/2006 - 05/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2006 - 07/2002
2	PD 176252IBA 01/2006 - 08/2003
2	Type I Vasoactive Intestinal Polypeptide ReceptorsIBA 12/2004 - 01/2004
2	(VIP-neurotensin) hybrid antagonistIBA 01/2004 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 11/2002
1	Neuregulin-1 (Neuregulin 1)IBA 07/2023
1	Trastuzumab (Herceptin)FDA Link 07/2023
1	Monoclonal AntibodiesIBA 07/2023
1	NeuregulinsIBA 08/2021
1	Therapeutic UsesIBA 01/2021
1	Retinaldehyde (Retinal)IBA 03/2018
1	AntioxidantsIBA 03/2018
1	nitroxylIBA 03/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2018
1	Growth Factor ReceptorsIBA 01/2018
1	CalciumIBA 01/2018
1	Type C PhospholipasesIBA 01/2018
1	AntibodiesIBA 01/2016
1	Cholecystokinin B ReceptorIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Superoxides (Superoxide)IBA 07/2015
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 07/2015
1	PD 134308IBA 07/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2015
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 07/2015
1	Sincalide FDA Link 07/2015
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 07/2015
1	gastrin 17 (G 17)IBA 07/2015
1	PaxillinIBA 01/2012
1	Oxygen (Dioxygen)IBA 08/2011
1	Neuroprotective AgentsIBA 02/2011

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2005
2	Lasers (Laser) 01/2004 - 07/2002